Device / Technology News

RSS

Researchers awarded $25 million NIH grant to study critical limb ischemia treatment

A team of researchers from Brigham and Women's Hospital, Boston Medical Center and Massachusetts General Hospital has been awarded $25 million by the National Institutes of Health to conduct a four-year, randomized clinical trial-the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia). The trial will compare traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia.

11 Dec 2013

FDA advisory committee votes in favor of WATCHMAN Left Atrial Appendage Closure device

The U.S. Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee voted favorably by a majority, Yes: 13, No: 1, that the benefits of the WATCHMAN Left Atrial Appendage Closure device outweigh the risks.

11 Dec 2013

FDA grants indication for GORE VIABAHN Endoprosthesis to treat thrombotic occlusion

W. L. Gore & Associates today announced that the Food and Drug Administration has granted indication for the GORE VIABAHN Endoprosthesis to treat stenosis or thrombotic occlusion at the venous anastomosis of synthetic arteriovenous access grafts.

11 Dec 2013

AlzeCure deploys Vortex tool to develop novel therapies for Alzheimer's disease

Dotmatics, a leading provider of scientific informatics solutions and services to the pharmaceutical and biotechnology industries, announced today that the research foundation AlzeCure, has deployed and integrated the data visualization and analysis tool Vortex. AlzeCure is a novel innovative drug discovery unit that will use Vortex to help in the quest to discover and develop novel therapies for the treatment of Alzheimer's disease and other neurodegenerative disorders.

11 Dec 2013

McKesson to launch new EnterpriseRx Flexible Delivery solution at ASHP Midyear Clinical Meeting

McKesson Pharmacy Systems and Automation is launching a new EnterpriseRx Flexible Delivery solution that expands the reach of outpatient and retail pharmacies beyond their local communities. The new solution will be introduced at the American Society of Health-System Pharmacists Midyear Clinical Meeting, which runs from December 8-12, 2013.

11 Dec 2013

SynCardia Systems sets new record with 150th implant of temporary Total Artificial Heart

SynCardia Systems, Inc. continues to set records with the implantation of the year's 150th SynCardia temporary Total Artificial Heart on Nov. 26, 2013.

11 Dec 2013

Surefire Medical enrolls patients in COSY clinical trial to investigate benefits of SIRT in liver metastasis

Surefire Medical, Inc. today announced that it has completed enrollment in the Coiling vs. Surefire Infusion System in Y90 (COSY) clinical trial.

11 Dec 2013

Researchers create two-part model of the skull for use in practicing neurosurgical techniques

Researchers from the University of Malaya in Malaysia, with collaboration from researchers from the University of Portsmouth and the University of Oxford in the United Kingdom, announce the creation of a cost-effective two-part model of the skull for use in practicing neurosurgical techniques. The model, produced using the latest generation of multimaterial 3D printers, is composed of a variety of materials that simulate the various consistencies and densities of human tissues encountered during neurosurgery.

11 Dec 2013

New antimicrobial coating prevents infections during cold winter months

With cold and flu season now in full swing, all-natural wellness provider Neutra Corp. (OTCBB: NTRR) is working quickly to deliver a revolutionary new antimicrobial coating that could soon prove to be the best defense against infections and viruses in the most notorious hotspot for the spread of these diseases: the classroom.

11 Dec 2013

New AquaLyse ionization technology prevents legionella and related disease outbreaks

With growing reports of Legionella and related Legionnaires' disease outbreaks in the USA, Canada and around the world, ProCare Water Treatment Inc. today announces its newest "AquaLyse® ICR-820" medical and commercial grade copper-silver ionization chamber cells.

11 Dec 2013

CatchMyPain App for patients suffering from chronic pain

Pain management as an independent medical field has been significantly growing during the last few decades. Doctors and clinics specialize in the treatment of pain in general and chronic pain specifically. These specialists often suggest using a pain diary to track the pain, see its development and adjust the treatment accordingly. CatchMyPain is an electronic version of such a pain diary and a great solution for patients suffering from chronic pain.

11 Dec 2013

EyeTechCare's new EyeOP1 device now available in six more French health care facilities

EyeTechCare SA, which develops non-invasive therapeutic medical devices for the ophthalmology market based on the use of ultrasound, today announces that six more health care facilities in France now have the new EyeOP1 device.

11 Dec 2013

BD Diagnostics introduces two ESR instruments to improve patient care in point of care settings

BD Diagnostics, a segment of BD, a leading global medical technology company, today introduced two new erythrocyte sedimentation rate instruments in Europe that standardise analysis for more accurate, timely results and an efficient workflow in comparison to a manual Westergren method. This next generation of BD ESR instruments results in improved patient care in the laboratory or point of care setting.

From BD (Becton, Dickinson and Company) 11 Dec 2013

CPAP treatment effective in patients with obstructive sleep apnea and hypertension

Among patients with obstructive sleep apnea and hypertension that requires 3 or more medications to control, continuous positive airway pressure treatment for 12 weeks resulted in a decrease in 24-hour average and diastolic blood pressure and an improvement in the nocturnal blood pressure pattern, compared to patients who did not receive CPAP, according to a study appearing in the December 11issue of JAMA.

11 Dec 2013

Simple and affordable hearing aids for children

Norwegian researchers are developing a simple and cheap hearing aid that can be adapted to compensate for a child's hearing loss without the need for specialists. The aim is to help more people in the third world.

11 Dec 2013

Echo Therapeutics signs strategic collaboration agreement with MTIA

Echo Therapeutics, Inc., a medical device company developing its Symphony CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it entered into a strategic collaboration agreement with Medical Technologies Innovation Asia, Ltd., Hong Kong, for a license arrangement and equity investment in Echo.

10 Dec 2013

Reverse Medical gets FDA clearance to market MVP-5 Micro Vascular Plug system in the US

Reverse Medical Corporation today announced FDA clearance for US commercialization of their MVP-5 Micro Vascular Plug system for peripheral vessel embolization, and the first US clinical case. The MVP-5 system is indicated for use to obstruct or reduce the rate of blood flow in the peripheral vasculature, in vessels measuring between 3.0 and 5.0 mm.

10 Dec 2013

FoundationOne Heme identifies clinically actionable genomic alterations in multiple myeloma cases

Foundation Medicine today announced new data from a pilot study demonstrating that its fully informative genomic profile for hematologic malignancies, FoundationOne Heme, identified both novel and previously reported clinically actionable genomic alterations in multiple myeloma cases. These data were presented in an oral presentation titled Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma (abstract number 755) by Alexander Lesokhin, M.D., medical oncologist, Memorial Sloan-Kettering Cancer Center, at the 55th American Society of Hematology Annual Meeting in New Orleans.

10 Dec 2013

INVISTA joins CPI for development of new technologies to enable gas-fermentation-based processes

INVISTA and The Centre for Process Innovation (CPI) announce a collaboration for the development of new technologies to enable gas-fermentation-based processes for the production of industrial chemicals.

10 Dec 2013

Computational predictive toxicology services available in SafeBridge Consultants

SafeBridge Consultants, Inc., a division of Trinity Consultants, Inc., Dallas, TX, with offices in Mountain View, CA, New York, NY, and Liverpool, UK, announces the availability of computational predictive toxicology services to the biopharmaceutical and chemical industry.

10 Dec 2013

Device / Technology News

Researchers awarded $25 million NIH grant to study critical limb ischemia treatment

FDA advisory committee votes in favor of WATCHMAN Left Atrial Appendage Closure device

FDA grants indication for GORE VIABAHN Endoprosthesis to treat thrombotic occlusion

AlzeCure deploys Vortex tool to develop novel therapies for Alzheimer's disease

McKesson to launch new EnterpriseRx Flexible Delivery solution at ASHP Midyear Clinical Meeting

SynCardia Systems sets new record with 150th implant of temporary Total Artificial Heart

Surefire Medical enrolls patients in COSY clinical trial to investigate benefits of SIRT in liver metastasis

Researchers create two-part model of the skull for use in practicing neurosurgical techniques

New antimicrobial coating prevents infections during cold winter months

New AquaLyse ionization technology prevents legionella and related disease outbreaks

CatchMyPain App for patients suffering from chronic pain

EyeTechCare's new EyeOP1 device now available in six more French health care facilities

BD Diagnostics introduces two ESR instruments to improve patient care in point of care settings

CPAP treatment effective in patients with obstructive sleep apnea and hypertension

Simple and affordable hearing aids for children

Echo Therapeutics signs strategic collaboration agreement with MTIA

Reverse Medical gets FDA clearance to market MVP-5 Micro Vascular Plug system in the US

FoundationOne Heme identifies clinically actionable genomic alterations in multiple myeloma cases

INVISTA joins CPI for development of new technologies to enable gas-fermentation-based processes

Computational predictive toxicology services available in SafeBridge Consultants

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News